Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report
December 16 2020 - 8:30AM
Business Wire
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of
modeling and simulation solutions for the pharmaceutical,
biotechnology, chemicals, and consumer goods industries, today
announced that it has published its inaugural Environmental,
Social, and Governance (“ESG”) report. The report summarizes the
Company’s commitment to the core principles of ESG, its performance
to date, and its aspirations for the future.
“At Simulations Plus, our vision is grand – to improve global
health – and we have adopted the mission of achieving this goal
through innovative, science-based software and consulting solutions
to optimize treatment options that will both save and improve the
quality of patients’ lives,” said Shawn O’Connor, chief executive
officer of Simulations Plus. “With our inaugural ESG report, we
have the opportunity to detail how Simulations Plus has, since its
founding in 1996, placed the highest emphasis on innovation,
integrity in our operations, commitment to producing positive
impacts, respect for our employees, and concern for our
communities.”
Mr. O’Connor continued, “At Simulations Plus, being good
corporate citizens is not a temporary pursuit for these times,
rather it is at the heart of everything we do, beginning with our
core mission of supporting our clients’ efforts to accelerate the
development and delivery of better, safer, and more effective
therapeutics with less impactful methodologies, to providing
consistent and excellent return to our shareholders. I am proud to
have this opportunity to show how our corporate values closely
align with the important principles of sustainable investing and
ESG.”
The Simulations Plus ESG report can be viewed on the Investors
page of its website under Corporate Profile.
About Simulations Plus, Inc.
Simulations Plus, Inc. is a leading provider of modeling and
simulation software and consulting services supporting drug
discovery, development research, and regulatory submissions. With
our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer
solutions which bridge machine learning, physiologically based
pharmacokinetics, quantitative systems pharmacology/toxicology, and
population PK/PD modeling approaches. Our technology is licensed
and applied by major pharmaceutical, biotechnology, chemical,
consumer goods companies and regulatory agencies worldwide. For
more information, visit our website at
www.simulations-plus.com.
Safe Harbor Statement Under the Private Securities Litigation
Reform Act of 1995 – With the exception of historical
information, the matters discussed in this press release are
forward-looking statements that involve a number of risks and
uncertainties. Words like “believe,” “expect” and “anticipate” mean
that these are our best estimates as of this writing, but there can
be no assurances that expected or anticipated results or events
will actually take place, so our actual future results could differ
significantly from those statements. Factors that could cause or
contribute to such differences include, but are not limited to: our
ability to maintain our competitive advantages, acceptance of new
software and improved versions of our existing software by our
customers, the general economics of the pharmaceutical industry,
our ability to finance growth, our ability to continue to attract
and retain highly qualified technical staff, our ability to
identify and close acquisitions on terms favorable to the Company,
and a sustainable market. Further information on our risk factors
is contained in our quarterly and annual reports and filed with the
U.S. Securities and Exchange Commission.
Follow us on Twitter | LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201216005352/en/
Simulations Plus Investor Relations
Ms. Renee Bouche 661-723-7723 renee@simulations-plus.com
Hayden IR Mr. Cameron Donahue
651-653-1854 slp@haydenir.com
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Apr 2023 to Apr 2024